Nuklearmedizin 1979; 18(06): 271-273
DOI: 10.1055/s-0037-1620913
Originalarbeiten – Original Articles
Schattauer GmbH

Cardiac Blood Pool Imaging — A Clinical Comparison between Red Blood Cells Labeled with 99mTc in vivo and in vitro and 99mTc-Labeled Human Serum Albumin

Szintigraphie der kardialen Blutmasse — Ein klinischer Vergleich zwischen mit 99mTc in vivo und in vitro markierten Erythrozyten und 99mTc-Humanalbumin
J. A. Dahlström
1   From the Departments of Clinical Physiology and Radiation Physics, University of Lund, General Hospital, Malmö, Sweden
,
S. Carlsson
1   From the Departments of Clinical Physiology and Radiation Physics, University of Lund, General Hospital, Malmö, Sweden
,
B. Lilja
1   From the Departments of Clinical Physiology and Radiation Physics, University of Lund, General Hospital, Malmö, Sweden
,
S. Mattsson
1   From the Departments of Clinical Physiology and Radiation Physics, University of Lund, General Hospital, Malmö, Sweden
,
C. Pettersson
1   From the Departments of Clinical Physiology and Radiation Physics, University of Lund, General Hospital, Malmö, Sweden
› Author Affiliations
Further Information

Publication History

Received: 27 August 1979

Publication Date:
09 January 2018 (online)

Summary

In 25 patients undergoing radiocardiographic determination of ventricular function, three methods for blood pool imaging were compared. 99mTc was used to label human serum albumin (HSA) and red blood cells (RBC) in vivo or in vitro. The activity concentration of 99mTc in blood was measured during 2 hrs after injection and a significantly higher concentration was found with RBC compared to HSA already after 15 min. The left ventricular to background count rate ratio was significantly lower for HSA after 90 min compared to RBC. There was no statistical difference in 99mTc activity concentration in blood or in left ventricular to background count rate ratio during the two hrs when the two RBC-labeling procedures were compared. 99mTc-labeled RBC are superior to 99mTc-labeled HSA for gated blood pool studies and especially for repeated determinations of ventricular function. Because the in vivo labeling is the most convenient method it has been adopted as the clinical routine at our hospital.

Zusammenfassung

Bei 25 Patienten, bei denen die Ventrikelfunktion radiokardiographisch untersucht wurde, wurden drei Methoden der Blutmassen-Szintigraphie verglichen. 99mTc wurde zur Markierung von Human-Serum-Albumin (HSA) und von Erythrozyten (RBC) in vivo oder in vitro verwendet. Die Aktivitätskonzentration des 99mTc im Blut wurde während 2 Std. nach der Injektion gemessen. Schon nach 15 Min. war die Konzentration des an die RBC gebundenen 99mTc signifikant größer als jene des an HSA gebundenen 99mTc. Die Quote der Impulsraten des linken Ventrikels und des Untergrundes war nach 90 Min. mit HSA signifikant kleiner als mit RBC. Es ergab sich keine statistische Differenz in der Aktivitätskonzentration des 99mTc im Blut oder in der Quote der Impulsraten des linken Ventrikels und des Untergrundes, wenn die beiden RBC-Methoden verglichen wurden. 99mTc-rnarkierte Erythrozyten sind für die Blutmassen-Szintigraphie besser geeignet als 99mTc-rnarkiertes HSA, besonders für wiederholte Bestimmungen der Ventrikelfunktion. Da die Methode mit in vivo markierten Erythrozyten die einfachste ist, wird sie als klinische Routinemethode in unserem Krankenhaus benützt.

 
  • References

  • 1 Berman D S, Salel AF, DeNaro GL, Bogren HG, Mason DT. Clinical assessment of left ventricular regional contraction patterns and ejection fraction by high-resolution gated scintigraphy. J. nucl. Med. 16: 865-874 1975;
  • 2 Dahlström J A, Hansson F, Lilja B, Mattsson S, Petersson C, Torp A. Determination of ejection fraction in congestive cardiomyopathy by means of radionuclide angiography. Proceedings of International Symposium on Clinical and Experimental Aspects of Cardiomyopathy (Editor M. Sekiguchi). Tokyo University Press (1980).
  • 3 Hegge F N, Hamilton GW, Larsson SM, Ritchie JL, Richards P. Cardiac chamber imaging: A comparison of red blood cells labeled with Tc-99m in vitro and in vivo. J. nucl. Med. 19: 129-134 1978;
  • 4 Mattsson S. Technetium-99 in “instant” 99mTc-pertechnetate. J. radioanal. Chem. 45: 341-347 1978;
  • 5 Seeker-Walker R H, Resnick L, Kunz H, Parker RL, Potchen EJ. Measurement of left ventricular ejection fraction. J. nucl. Med. 14: 798-802 1973;
  • 6 Smith T D, Richards P. A simple kit for the preparation of 99mTc-labeled red blood cells. J. nucl. Med. 17: 126-131 1976;
  • 7 Snedecor GW. Statistical Methods Applied to Experiments in Agriculture and Biology. Fifth edition. The Iowa State University Press (1956).
  • 8 Stokely E M, Parkey RW, Bonte FJ, Graham KD, Stone MJ, Willerson JT. Gated blood pool imaging following 99mTc stannous pyrophosphate imaging. Radiology 120: 433-434 1976;
  • 9 Strauss H W, Zaret BL, Hurley PJ, Natarajan TK, Pitt B. A scintiphotographic method for measuring left ventricular ejection fraction in man without cardiac catheterization. Amer. J. Cardiol. 28: 575-580 1971;
  • 10 Thrall J H, Freitas JE, Rogers WL, Clare JM, Brown ML, Pitt B. Clinical comparison of cardiac blood pool visualization with technetium-99m red blood cells labeled in vivo and with technetium-99m human serum albumin. J. nucl. Med. 19: 796-803 1978;
  • 11 Zaret B L, Strauss HW, Hurley PJ, Natarajan TK, Pitt B. A non-invasive scintiphotographic method for detecting regional ventricular dysfunction in man. New Engl. J. Med. 284: 1165-1170 1971;